Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
COMBINE (Acamprosate/Naltrexone)
This study has been completed.
Study NCT00006206.   Last updated on November 27, 2007.
Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00006206
Locations
United States, Connecticut
Substance Abuse Treatment Unit, Yale University
New Haven, Connecticut, United States, 06511
United States, Florida
University of Miami School of Medicine
Miami, Florida, United States, 33136
United States, Massachusetts
Boston University School of Medicine
Boston, Massachusetts, United States, 02118
Harvard University/McLean Hospital
Belmont, Massachusetts, United States, 02478
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
United States, New Mexico
Center on Alcoholism, Substance Abuse and Addiction, University of New Mexico
Albuquerque, New Mexico, United States, 87106
United States, Pennsylvania
Treatment and Research Center, University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
United States, Rhode Island
Roger Williams Medical Center , Brown University
Providence, Rhode Island, United States, 02908
United States, South Carolina
Center for Alcohol Programs, Medical University of South Carolina
Charleston, South Carolina, United States, 29425
United States, Texas
Southwest Texas Addiction Research and Technology Center, University of Texas Health Science Center
San Antonio, Texas, United States, 78229
United States, Washington
Addictions Treatment Center, University of Washington
Seattle, Washington, United States, 98108
United States, Wisconsin
University of Wisconsin-Milwaukee
Milwaukee, Wisconsin, United States, 53233
Sponsors and Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Lipha Pharmaceuticals
Investigators
Study Chair: Ray Anton, M.D. Medical University of South Carolina, Charleston, SC